Home | Welcome to Contract Pharma   
Last Updated Friday, January 30 2015

Print

Topics - APIs


Refine by Date:
From: To:
Pharmaceutical Fine Chemicals…Quo Vadit?
By Dr. Enrico T. Polastro , Arthur D. Little
Published January 29, 2015
Captive and merchant demand estimated at $80 billion and growing 4-5% per annum. Read More »
Published January 28, 2015
To manufacture Amotosalen API for Cerus Read More »
Published January 19, 2015
Will support development and manufacture of drug candidates for neurological disorders Read More »
Published December 15, 2014
Broadens access to key biotech hubs Read More »
Published December 10, 2014
Werum's PAS-X V3.1.5 covers areas of API manufacturing and product warehouse Read More »
Published December 4, 2014
Expands sterile filling segment Read More »
Published December 1, 2014
Attributes growth to rapidly developing biopharma industry and increase in CMOs globally Read More »
Published November 21, 2014
Expands capacity for immunology and oncology pipelines Read More »
Published November 17, 2014
Warburg Pincus invests $92mn in the Indian maker of APIs. Read More »
Published October 21, 2014
Expands drug development and bioavailability capabilities Read More »
Published October 15, 2014
Increasing GMP issues may threaten patient safety unless QbD adoption grows Read More »
Published October 13, 2014
Will offer newly developed galenic forms Read More »
Published October 2, 2014
Aims to develop scalable and cost-effective process for a targeted API Read More »
Published September 4, 2014
Complies with the quality GMP & GDP standards Read More »
Published August 20, 2014
Expands geographic scale, manufacturing and lyophilization capabilities Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On